September 1, 2025

Glaukos Corporation (GKOS) Stock Analysis: A Healthcare Innovator with 27.8% Potential Upside

Investors looking for exposure in the healthcare sector, particularly in cutting-edge medical devices, may find Glaukos Corporation (NYSE: GKOS) an intriguing option. Known for its innovative..

Humana Inc. (HUM) Stock Analysis: Is the Current Price Offering a Strategic Investment Opportunity?

For investors eyeing opportunities in the healthcare sector, Humana Inc. (NYSE: HUM) presents a fascinating case. As a leading provider of medical and specialty insurance products..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A 46% Upside Potential with Strong Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, is capturing investor attention with its robust portfolio and promising upside potential. Based in..

Abbott Laboratories (ABT) Stock Analysis: Steady Growth and a 7.41% Potential Upside

Abbott Laboratories (NYSE: ABT), a prominent player in the healthcare sector, continues to capture the attention of investors with its robust market performance and diversified product..

Tenet Healthcare Corporation (THC): Investor Outlook Highlights 7.16% Potential Upside and Strong Buy Ratings

Tenet Healthcare Corporation (NYSE: THC) is firmly positioned in the healthcare sector, specifically within the medical care facilities industry, and it has carved out a significant..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Biotech Powerhouse with 16.42% Potential Upside

For investors keeping a keen eye on the biotechnology sector, BeOne Medicines Ltd. (ONC) emerges as a compelling candidate. This Swiss-based oncology company, with a significant..

Fresenius Medical Care AG (FMS) Stock Analysis: Exploring 18% Potential Upside in Healthcare Sector

Fresenius Medical Care AG (NYSE: FMS) is a prominent name in the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating the Volatility with Strategic Insights

Investors with a keen eye on the healthcare sector, particularly those interested in niche markets like Traditional Chinese Medicine (TCM), may find Regencell Bioscience Holdings L..

Natera, Inc. (NTRA) Stock Analysis: A Diagnostic Powerhouse with a 17.56% Potential Upside

Natera, Inc. (NTRA), a prominent player in the healthcare sector, has carved a niche for itself in the diagnostics and research industry. Headquartered in Austin, Texas,..

The Ensign Group, Inc. (ENSG) Stock Analysis: Navigating a 0.71% Upside with Robust Revenue Growth

The Ensign Group, Inc. (NASDAQ: ENSG), a key player in the healthcare sector, is catching the attention of investors with its robust performance metrics and promising..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating a Stable Path with Limited Upside Potential

Investors seeking exposure to the healthcare sector through a player in the diagnostics and research industry may find Mettler-Toledo International, Inc. (NYSE: MTD) an intriguing option...

Walgreens Boots Alliance (WBA) Stock Analysis: Navigating a High Dividend Yield Amidst Challenging Metrics

For investors with an eye on the healthcare sector, Walgreens Boots Alliance, Inc. (NASDAQ: WBA) presents a compelling if complex opportunity. As a leading player in..

Charles River Laboratories (CRL) Stock Analysis: Healthcare Innovator with a 5.36% Upside

Charles River Laboratories International, Inc. (NYSE: CRL), a prominent name in the healthcare sector’s diagnostics and research industry, continues to capture investor attention. With a market..

DexCom, Inc. (DXCM) Stock Analysis: A 35% Potential Upside Beckons Investors

DexCom, Inc. (NASDAQ: DXCM) stands as a beacon of innovation within the healthcare sector, specifically in the medical devices industry. Known for its pioneering work in..

United Therapeutics Corporation (UTHR) Stock Analysis: A Deep Dive into 24.87% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR) stands out as a promising player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. As the..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring 19.37% Potential Upside for Investors

Merck & Company, Inc. (NYSE: MRK) continues to be a formidable presence in the healthcare sector, boasting a market capitalization of $210.11 billion. As a leading..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a 16% Potential Upside Amid Global Biopharmaceutical Expansion

Pfizer, Inc. (NYSE: PFE), a titan in the healthcare sector, commands significant attention with its expansive portfolio in the drug manufacturing industry. Headquartered in the bustling..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a 7.42% Potential Upside and Robust Revenue Growth

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a leading player in the healthcare sector specializing in diagnostics and research, is capturing investor attention with its impressive market cap..

Labcorp Holdings Inc. (LH) Stock Analysis: Solid Growth and Potential Upside Make It a Compelling Healthcare Play

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, stands out in the Diagnostics & Research industry with a market capitalization of $23.1..

Alnylam Pharmaceuticals, Inc. (ALNY) Investor Outlook: Navigating Biotech Innovation with Strong Buy Ratings

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands at the forefront of the biotechnology sector, garnering significant attention from investors and analysts alike. With a market capitalization of..

Search

Funds

September 1, 2025

Search

Funds

September 1, 2025

FTSE 100

Funds